RANI - Rani Therapeutics Holdings Inc. (RANI) Q4 2023 Earnings Call Transcript
2024-03-20 19:05:06 ET
Rani Therapeutics Holdings, Inc. (RANI)
Q4 2023 Earnings Conference Call
March 20, 2024, 04:30 PM ET
Company Participants
Kiki Patel - Gilmartin Group LLC
Talat Imran - Chief Executive Officer
Arvinder Dhalla - Vice President, Clinical Development
Svai Sanford - Chief Financial Officer
Conference Call Participants
Olivia Brayer - Cantor Fitzgerald
Edward Nash - Canaccord Genuity
Julian Harrison - BTIG
John Vandermosten - Zacks
Presentation
Operator
Welcome to Rani Therapeutics Fourth Quarter and Full Year 2023 Financial Results and Corporate Update Conference Call. At this time, all participants are a in a listen-only mode. Following management's prepared remarks, we will hold a Q&A session. To ensure that we have ample time to address everyone's questions during the Q&A session, we would ask for a limit of one question and one follow-up question per person. [Operator Instructions] As a reminder, this call is being recorded today Wednesday, March 20, 2024.
I would now like to turn the conference call over to Kiki Patel at Gilmartin Group. Please go ahead.
Kiki Patel
Thank you, operator. Joining us on the call today from Rani Therapeutics' are Chief Executive Officer, Talat Imran; VP of Clinical Development, Arvinder Dhalla, and Chief Financial Officer, Svai Sanford....
Rani Therapeutics Holdings, Inc. (RANI) Q4 2023 Earnings Call Transcript